Back

Five-year changes in weight and risk of atrial fibrillation in women and men from the Danish diet, cancer, and health cohort

27 August 2023 (12:15 - 12:50)
Organised by: Logo
Congress Presentation Part of: Risk factors: obesity (1) Obesity ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Ms Tanja Charlotte Frederiksen

Aarhus University Hospital, Aarhus (Denmark)

5 More presentations in this session

Presentation thumbnail
Epicardial fat is associated with adverse ventricular remodeling and diastolic dysfunction in women with ischemia but no obstructive coronary artery disease
Miss S. Zamani (Arlington, US)
Abstract Slides Video
Presentation thumbnail
Association between body mass index and outcomes in heart failure across the ejection fraction spectrum: data from the Swedish Heart Failure Registry
Doctor G. Ferrannini (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
DOACs or warfarin use in morbidly obese patients (BMI > 40 kg/m2) on anticoagulant therapy? : a systematic review and meta-analysis
Doctor M. Sagris (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Prevalence of SELECT-eligibility and incidence of 5-year major adverse cardiovascular outcomes in non-diabetic patients with myocardial infarction
Professor M. Maeng (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Effect of diabetes duration on subclinical target organ damage in young diabetic adults with type 1 diabetes mellitus
Doctor E. Kowalczyk (Lodz, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factors: obesity (1)

The Event

Event poster

ESC Congress 2023

27 August 2023 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Long-term weight change in midlife, cardiac magnetic resonance parameters, risk of atrial fibrillation: a large prospective cohort study
thumbnail
Congress Presentation
Atrial fibrillation: obesity matters
thumbnail
Congress Presentation
Weight change does not impact the long-term outcomes following pulmonary vein isolation in obese patients with atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources